Please login to the form below

Not currently logged in
Email:
Password:

Cardinal Health hires new executive VP of strategy and corporate development

US-based drug delivery and healthcare company Cardinal Health hires Mr Vivek Jain as executive vice-president of strategy and corporate development

US-based drug delivery and healthcare company Cardinal Health has hired Mr Vivek Jain as executive vice-president of strategy and corporate development.

Jain will be responsible for long-range planning and mergers and acquisitions that complement the company's organic growth goals. He will report to R Kerry Clark, Cardinal Health's CEO.

Jain will join Cardinal Health on 20 August 2007. He previously served as senior vice-president at Philips Medical Systems. He replaces Brendan Ford, who is retiring from the company after 16 years in the legal and corporate development functions.

Jain is a 13-year veteran of the health-care industry with a broad range of strategic planning and merger experience for pharmaceutical and medical device companies. Prior to Philips, he was an investment banker at JP Morgan Securities or its predecessor companies for more than a decade. In 2002, he was named co-head of the global health-care investment banking group and has been primarily focused on the pharmaceutical, medical device and diagnostics sectors for his entire career.

14th August 2007

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics